Cleveland Diagnostics pockets $17.4m Series D

Cleveland Diagnostics Inc, a developer of next-generation diagnostic tests for the early detection of cancers, has secured $17.4 million in Series D funding.

Cleveland Diagnostics Inc, a developer of next-generation diagnostic tests for the early detection of cancers, has secured $17.4 million in Series D funding. LYFE Capital led the round.

Source: Press Release